Rani Therapeutics Holdings, Inc.
RANI
$1.05
-$0.05-4.55%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 1.15% | -0.52% | 2.93% | 9.92% | 11.63% |
| Total Depreciation and Amortization | -12.45% | -0.91% | 7.17% | 16.89% | 25.06% |
| Total Amortization of Deferred Charges | -10.78% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Other Non-Cash Items | 146.72% | 95.87% | 84.64% | 73.30% | 61.72% |
| Change in Net Operating Assets | 1,379.04% | 93.84% | 79.16% | -17.17% | 74.58% |
| Cash from Operations | 47.28% | 29.64% | 31.41% | 29.37% | 30.72% |
| Capital Expenditure | 67.16% | 70.54% | 67.81% | 69.87% | 78.19% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -134.58% | -14.16% | -36.09% | -24.26% | -35.42% |
| Cash from Investing | -135.49% | -13.41% | -35.52% | -23.00% | -33.66% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -314.44% | -1,100.00% | -- | -- | -- |
| Issuance of Common Stock | 488.58% | 61.69% | 5,133.04% | 5,184.11% | 5,056.96% |
| Repurchase of Common Stock | -25.53% | -23.68% | -1.89% | -84.21% | 70.99% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -157.02% | 27.48% | -- | -- | -- |
| Cash from Financing | 196.65% | -86.77% | 2,302.95% | 2,713.01% | 5,730.47% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 792.48% | 80.86% | 287.69% | 126.71% | 90.06% |